BiotechTube
Home/Matinas Biopharma/Edward Neugeboren
EN

Edward Neugeboren

Board Member, Chair of Compensation Committee

Matinas Biopharma

Therapeutic Areas

Infectious DiseaseInflammationOncology

Matinas Biopharma Pipeline

DrugIndicationPhase
MAT2203Invasive Fungal Infections (Candidiasis, Aspergillosis)Phase 2/3
LNC Platform DiscoveryOncology & InflammationDiscovery

Leadership Team at Matinas Biopharma

JD
Jerome D. Jabbour
Chief Executive Officer
KM
Keith Murphy
Board Member, Chair of Nominating and Governance Committee
ED
Evelyn D’An
Board Member, Audit Committee Chair
RL
Robin L. Smith
Board Member
View full Matinas Biopharma profile